Professional Documents
Culture Documents
1
.2 :
.1 :
.2
.3
.3
: )(
) +(
MAINTENANCE
EMERGENCE
.1 ,,
.2
.3
.4
.5 < <
-
) (
,
:
1
2
3
4
) (
AWARENESS
:
.1
.2 ,
.3 , ,
.4 ,
, :
.
, )
(.
HYPOXIA DIFFUSION
, -
, 21% "
10
,
'
/
,
) (
PERIPHERAL NEUROPATHY -
ASA SCORE
American Society of Anasthesiologist
-1 .
-2
.
-3
-4
24 - \
-5
-6
Emergency = E
. :
. :
.1
.2
.3
.4
.5
.6
.1
:
: GABA(Gama Amino Butric Acid -
.
.
( THIOPENTAL (Pentothal:
:
- .
- ) ( .
- . , .
:
, - , , 1%-5% - , , - - ,
:
- -
- " GABA -" ,
: (PROPOFOL(diprivan
GABA
" ,"HANG OVER
:
-
-
-
:
) (
-
:
\
.2
" .
: ,
.
) FENTANYL ,MORPHINE: 100(.
:
- MO .
,.
- )
(
.3
- " ,
.GABA ,
.
:
(MIDAZOLAM (DORMICUM
-(LORAZEPAM (LORINAN
-(DIAZEPAM (VALIUM, ASSIVAL
:
-
- CO2-
-
:
- , )(
-
.4
(KETAMINE(KETALAR
-
, , .
" " - ,
,
) (.
, .
:
- .
-
) (
.5
:
\
) (
:
DEPOLERIZING MUSCLE RELAXANTS.1
NON DEPOLERIZING MUSCLE RELAXANTS .2
) (mg0.5-1
:
, ,
-MALIGNANT HYPERTHERMIA
)NORCURON) VECURONIUM
Intermediate onset and duration
:
:
)Pancuronium-Long acting(
:
:
: -
.
NEOSTIGMIN
NON DEPOLERIZING
.
:
) ( ,,
.
:
.
,
.
:
SEBOFLORANE -
- ISOFLURANE
- NITROS-N20
:
-
)
(
:
MALIGNANT HYPERTHERMIA-
:NITROS-N2O
,
TYMPANOPLASTY,-
PNEUMOTHORAX
20%
DNA
, ,
MALIGNANT HYPERTHERMIA .
.
) (NITROS.
:
)CO2-(
1-2 5
.
:
:
: ,
"
:
COPD
CO2
,
.
80% 5%
:
100%
,VEPORIZER"
DANTROLENE -
" ++CA
ARTERIAL LINE
"
:
, -
Foramen Magnum-
7 Cervical-, 12-
Thoracic ,5 Lumbar ,5-.Sacral, 4 Coccyx -
- Spinous-
process
.
Ligamentum
Flavum
L1-2 L2-3
-
.Cauda Equina
CSF , -
.
, - .
CSF
)(.
-
.
Iliac Crest - L4Spinous -
Process
.
.
--
,
60-30
...
-
-BARICITY :
-Hyperbaric" .
.
"
-
T6
-Hypobaric"
.
-Isobaric L1
- - -
)
25%-50%-(.
.
. . -
, ,
)-(
,
. CSF
.
. .
- , , ,
.Blood Patch -
Spinal High , T3 ,
, ,CO2 . ,
. .
- , . .
. .
. .
.
Iliac Crest- L4Spinous Process -
.
G18 .
""
.
Ligamentum Flavum
".Loss Of Resistance
--
.
, ,
.
,
)
(
)(.
3-1 .
20-5 .
,
.
6-8.
-High Spinal 3
,
.
10
) CC 15-20.(CC 1-2
-
. .
- . , ,
,.
, .
.
.
.
.
,
, ""
,
.
, .
.
,ECG :.,Pulse Oximeter -
) "( ,
, .
1% 3-4" 1/" .
10=1%"/"
4" X 70" = 280"= 28"
15 .
.
.
,
.